🇺🇸 Doxycyline in United States

FDA authorised Doxycyline on 9 December 1983 · 109 US adverse-event reports

Marketing authorisations

FDA — authorised 9 December 1983

  • Application: ANDA062475
  • Marketing authorisation holder: FRESENIUS KABI USA
  • Local brand name: DOXY 100
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Haemorrhage — 14 reports (12.84%)
  2. Nausea — 14 reports (12.84%)
  3. Dizziness — 12 reports (11.01%)
  4. Fatigue — 12 reports (11.01%)
  5. Headache — 12 reports (11.01%)
  6. Diarrhoea — 10 reports (9.17%)
  7. Dyspnoea — 10 reports (9.17%)
  8. Drug Ineffective — 9 reports (8.26%)
  9. Abortion Incomplete — 8 reports (7.34%)
  10. Vomiting — 8 reports (7.34%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Doxycyline approved in United States?

Yes. FDA authorised it on 9 December 1983; FDA has authorised it.

Who is the marketing authorisation holder for Doxycyline in United States?

FRESENIUS KABI USA holds the US marketing authorisation.